Advanced Breast Cancer Recruiting Phase 2 Trials for Everolimus (DB01590)

Also known as: Malignant neoplasm of breast / Malignant breast neoplasm / Breast cancer / Breast tumor malignant / Breast tumour malignant / Breast cancer NOS / Breast cancer stage unspecified / Ca breast

DBCOND0031019 (Advanced Breast Cancer)Recruiting2 IdentifierTitlePurposeDrugs
NCT03312738A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase InhibitorTreatment